Advertisements

Doliprane 2.4%

Quick links to important sections

Doliprane 2.4%

Advertisements

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Doliprane 2.4%

Doliprane 2.4% is an orally administered pharmaceutical preparation classified as a non-opioid analgesic (pain reliever) and antipyretic (fever reducer). It is a widely available medication whose general purpose is to provide symptomatic relief from common discomfort and high body temperature.

Property Description
Active ingredient Acetaminophen (Paracetamol)
Form Oral Suspension (2.4% concentration)
Pharmacological class Analgesic and Antipyretic
Common use General pain and fever relief
Origin Synthetic

What Type of Medicine is Doliprane 2.4%?

This medication belongs to the pharmacological class of analgesics and antipyretics, serving to mitigate the body's perception of pain and regulate its internal temperature. It is a single-ingredient product, containing only one active therapeutic compound. Acetaminophen is primarily grouped as an analgesic and antipyretic. Unlike nonsteroidal anti-inflammatory drugs (NSAIDs) such as Ibuprofen, this substance is generally not associated with significant anti-inflammatory action.

Composition: What is the Active Ingredient?

The sole active ingredient in this medication is Acetaminophen, the chemical name for the substance widely known in many countries as Paracetamol. Paracetamol is recognized as an essential medicine due to its established role in global healthcare. This active compound is synthetic, manufactured through chemical processes. The 2.4% concentration specifies the exact amount of Acetaminophen suspended within the liquid formulation.

Why is it an Oral Suspension?

Doliprane 2.4% is formulated as an oral suspension, a liquid dosage form where the active compound is finely dispersed in an aqueous (water-based) vehicle. The medication is designed for direct oral administration. The suspension form is often chosen to enhance palatability and to allow for accurate and flexible dosing, which is particularly useful for various age groups and those who may find it challenging to swallow solid tablets.

Regulatory References

  1. U.S. National Library of Medicine
  2. World Health Organization (WHO)
  3. Essential Medicine
Advertisements

What side effects are possible with Doliprane 2.4%?

Official Safety Profile of Acetaminophen (Paracetamol)

The official safety profile for Acetaminophen, the active ingredient in Doliprane 2.4%, is organized by regulatory agencies to describe documented adverse reactions and crucial safety characteristics. The majority of individuals tolerate the medicine well at therapeutic dosages, but the regulatory labeling specifies potential risks.

Serious Adverse Reactions and Frequency Classification

The most critical safety concerns highlighted in official documents relate to the liver and immune system, generally classified as very rare or of not known frequency based on available post-marketing data. Severe adverse reactions include acute liver failure, which is predominantly associated with exceeding the maximum daily dose. Other serious risks are severe skin reactions, such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), and serious hypersensitivity reactions, including anaphylactic shock.

System-Organ Classes Involved

Adverse effects are formally grouped into system-organ classes, with documented effects concerning the Hepatobiliary Disorders (liver), Immune System Disorders (allergic responses), Skin and Subcutaneous Tissue Disorders, and Blood and Lymphatic System Disorders (blood dyscrasias).

Safety Constraints and Specific Populations

The official label mandates specific constraints to prevent severe outcomes. The medicine is contraindicated for individuals with severe hepatic impairment or active liver disease. Caution is advised for patients with chronic malnutrition, chronic alcoholism, or severe renal impairment, where the risk of adverse reactions is increased. Furthermore, cases of liver injury are frequently linked to the use of multiple products containing acetaminophen.

Exposure-Related Safety Patterns

Safety notes specify that the risk of serious liver damage is delayed and may become apparent 12 to 48 hours following an overdose. Separately, prolonged, regular daily use may enhance the effect of oral anticoagulants, raising the risk of bleeding.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Immediate medical attention is mandatory for any suspected overdose.

Paracetamol (the active ingredient in Doliprane) overdose is a medical emergency due to the significant risk of delayed, severe liver damage (acute hepatic necrosis). The most serious outcomes, including acute liver failure, may not become clinically apparent until 24 to 72 hours after ingestion.

Documented Overdose Manifestations

Overdose Phase Signs and Symptoms
Initial Phase (0–24 hrs) Nausea, vomiting, pallor, anorexia, and sweating (diaphoresis). These are non-specific and may temporarily resolve.
Later Phase (24–72 hrs) Right upper quadrant abdominal pain, elevated liver enzymes (transaminases), and signs of hepatic injury (jaundice).

Required Emergency Action

You must seek urgent medical assessment immediately, regardless of initial symptoms or the amount taken. Do not wait for symptoms to worsen.

Regulatory protocols confirm that the specific antidote, N-acetylcysteine (NAC), is required. The effectiveness of NAC is time-dependent, making rapid hospital transfer and assessment critical. Treatment is guided by the measurement of the paracetamol plasma concentration, often plotted against a treatment nomogram.

Population-Specific Overdose Note: Individuals with chronic alcohol use, malnutrition, or those taking certain enzyme-inducing medicines may have a higher risk of severe toxicity at lower doses.

Advertisements

Therapeutic Uses of Doliprane 2.4%

What Doliprane 2.4% Treats: Main Uses and Benefits

Doliprane 2.4% is a non-opioid analgesic and antipyretic relevant for symptomatic relief across acute episodes of discomfort. Its therapeutic application focuses on managing symptom clusters where a key benefit is reducing distress and supporting a better patient experience during transient illness. The medication is generally used to help with pain and to reduce fever across various conditions.

The medicine may be applied to address symptoms related to mild to moderate pain and systemic imbalance, including headache, earache, musculoskeletal discomfort, and pyrexia (fever) associated with the common cold or viral infections. It is commonly used in situations involving symptoms that appear suddenly, such as during flu-like syndromes or following vaccination reactions.

“Providing support that may ease the overall symptom burden is central to managing acute, self-limiting illnesses.”

The primary benefit is that it plays a role in managing elevated body temperature and helps address painful sensations, which contributes to improved comfort during periods of heightened symptoms. This supportive care may assist with maintaining a sense of stability, particularly for pediatric patients and others who require a liquid formulation.


Quick Fact: Targets Fever and Mild Pain Symptoms


Regulatory References

  1. NIH MedlinePlus overview on Acetaminophen
Advertisements

Eligibility and Restrictions for Use

The official regulatory profile for Doliprane 2.4% (Paracetamol Oral Suspension) defines eligibility based on age, weight, and pre-existing health conditions, as it is a medicine primarily reserved for the pediatric population.


Eligibility Scope

Category Official Regulatory Rule
Populations for whom use is allowed: Infants and Children within specific weight parameters (e.g., 3 kg to 26 kg). Adults and older children typically use other formulations.
Populations for whom use is contraindicated: Individuals with known hypersensitivity to paracetamol or excipients, or with severe hepatic impairment (severe liver disease).

Eligibility-Related Restrictions

Conditional use is mandatory for several populations, requiring medical supervision or caution:

  • Organ Impairment: Patients with non-severe hepatic impairment or severe renal impairment must use the medicine with caution. The risk of liver toxicity is higher in those with chronic alcoholism or malnutrition.
  • Excipient-Based Restriction: The presence of specific excipients (e.g., Sorbitol) makes the medicine contraindicated for patients with Hereditary Fructose Intolerance.
  • Pregnancy and Lactation: Use during pregnancy is permitted only at the lowest effective dose for the shortest duration possible. Use during breastfeeding is generally compatible at recommended therapeutic doses.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for this product, which contains Acetaminophen (Paracetamol), is defined by pharmacokinetic and pharmacodynamic relationships documented in official regulatory sources.

Contraindicated Combination

Co-administration with any other medicinal product containing Acetaminophen is strictly prohibited to prevent exceeding the recommended daily limits and risking severe hepatotoxicity (acute liver failure), as explicitly stated in regulatory labeling.


Clinically Significant Drug-Drug Interactions

Interacting Substance/Class Official Interaction Pattern
Coumarin Anticoagulants (e.g., Warfarin) Pharmacodynamic Amplification: Prolonged regular daily use may enhance the anticoagulant effect, leading to an increased International Normalized Ratio (INR) and a risk of bleeding.
Hepatic Enzyme Inducers (e.g., Rifampicin, Carbamazepine, Phenytoin) Metabolic Risk Enhancement: Increase the formation of a toxic intermediate metabolite, significantly raising the potential for liver damage.
Flucloxacillin Population-Specific Risk: Concurrent use is associated with a risk of High Anion Gap Metabolic Acidosis (HAGMA), particularly in patients with predisposing factors for glutathione depletion (e.g., severe illness, chronic alcoholism).

Exposure and Administration Constraints

Substances like Metoclopramide and Domperidone increase the rate of absorption. Conversely, the substance Cholestyramine reduces absorption and requires administration to be separated by at least one hour to avoid a pharmacokinetic interaction. Chronic daily ingestion of alcohol (ethanol) is documented to enhance the hepatotoxicity risk.

Advertisements

Mechanism of Action

The mechanism of Acetaminophen (Paracetamol) is defined by its targeted intervention in key regulatory systems within the Central Nervous System (CNS), influencing both thermoregulation and nociceptive signaling.

The primary molecular action involves the inhibition of Cyclooxygenase (COX) enzymes, particularly central isoforms, which reduces the synthesis of Prostaglandin E2 (PGE2), a key molecular mediator. This modification alters signaling dynamics within targeted pathways.

The reduction of PGE2 in the hypothalamus triggers the core antipyretic cascade by causing a functional reset of the body's thermoregulatory set point. This initiates a chain of physiological adjustments, including peripheral vasodilation and sweating, that influence regulatory feedback mechanisms within the thermoregulatory pathway.

Beyond enzyme inhibition, the mechanism involves multi-modal modulation of nociceptive signaling, including interaction with the TRPV1 receptor and the endocannabinoid system via an active metabolite. This engagement of multiple central pathways reduces the excitability of pain signaling and influences the activity of the body's intrinsic pain control systems.

Advertisements

Dosage and Administration Information

How to Use Doliprane 2.4%: Official Administration Guidelines

This section details the standardized administration protocols for Acetaminophen (Paracetamol) Oral Suspension.

Instruction Detail
Route of Administration Oral only, via the liquid suspension formulation.
Preparation Requirements The bottle must be shaken well for at least 10 seconds before the dose is measured to ensure uniform suspension.
Measurement Tool Doses must be measured using the calibrated oral administration syringe or device provided with the product.
Timing in Relation to Meals The medication may be taken with or without food.

Dosing Principles and Frequency

The dosage for this oral suspension is based fundamentally on the patient's body weight, not age. The standard single dose is 10 to 15 mg per kg of body weight. A strict minimum interval of 4 hours must be observed between administrations to prevent accumulation of the active ingredient, and doses may be repeated up to four times daily.

The maximum total daily intake of Paracetamol, from all sources, must not exceed 60 mg/kg/day for most pediatric patients. The use of the suspension is intended for short-term symptomatic relief only, typically not exceeding three days for fever or five days for pain without re-evaluation.

Population and Co-Administration Rules

Established protocols mandate that dose adjustments or frequency reductions are required for patients with severe hepatic or renal impairment due to altered clearance rates. Furthermore, it is a critical procedural requirement not to administer concurrently with any other prescription or non-prescription product that contains Paracetamol (Acetaminophen).

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Doliprane 2.4%


Evidence for use in Treating Fever

Research has explored the use of Doliprane 2.4% in conditions characterized by fluctuating or episodic manifestations where fever is present. Studies conducted to date have focused on understanding outcomes related to systemic or functional imbalance, specifically the tracking of elevated body temperature. These trials have monitored how body temperature evolved in the observed populations over defined time intervals.

The findings describe patterns observed in the studies, which suggest that Doliprane 2.4% was studied for its use in cases of fever. Research highlights data captured during the study period relevant to the intensity of the fever. However, certainty remains low regarding how individuals will respond, and long-term effects are not fully established for this use.


Evidence for use in Treating Pain

Doliprane 2.4% was evaluated in research exploring conditions involving periods of heightened symptoms such as mild to moderate pain. The types of studies that exist are primarily short-term trials that have been applied in studies examining patient-reported experiences of pain and outcomes related to physical discomfort.

Studies explored the use of the medicine in settings with varying symptom burdens. Findings indicate that the medicine was observed in research where changes in patient-reported outcomes describing perceived discomfort were measured. This evidence contributes to understanding symptom patterns over short periods.


Long-term studies and follow-up

Research has examined what happens after the initial short-term use of Doliprane 2.4%. Currently, long-term effects are not fully established. Evidence is limited regarding the use of Doliprane 2.4% over many months or years. Follow-up durations were limited in many key studies. Data show patterns related to short-term changes, but the long-term impact is an area where research is ongoing.


Evidence in special populations

Doliprane 2.4% was studied for its use in specific populations, most notably children. Studies explored how the medicine was observed in this group, focusing on outcomes describing conditions like inflammatory or irritative states and fever. For certain populations, such as older adults or those with comorbid conditions, subgroup findings are uncertain, and data for certain groups remain insufficient.


What is still uncertain about Doliprane 2.4%

While Doliprane 2.4% was evaluated in studies for fever and pain, comparative evidence is lacking in certain areas. There are gaps concerning long-term effects are not fully established and for populations where data for certain groups remain insufficient. Evidence quality varies across studies, and findings were mixed in some research. This highlights areas where more research is needed.

Key Studies & References

  1. Efficacy of paracetamol for acute pain: an overview of systematic reviews
  2. Acetaminophen (Paracetamol) Official Drug Labeling Information (FDA)
  3. The role of paracetamol in non-malignant chronic pain: an updated systematic review
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Doliprane 2.4% (FAQ)

Q: How quickly should I expect Doliprane 2.4% to start working after taking it?

A: Studies on the active ingredient, paracetamol, indicate that it is absorbed readily after oral administration. Regulatory documents show that peak concentration of the medicine in the blood is typically reached about 10 to 60 minutes after the dose is taken. This timeframe suggests when the onset of pain or fever relief is typically observed in studies.

Q: What is the typical duration of pain relief from a single administration of Doliprane 2.4%?

A: Official administration guidelines require that a strict minimum interval of 4 hours be observed between administrations. This minimum time interval is required by regulatory bodies to prevent the medicine from accumulating in the body and exceeding safe levels.

Q: Are there any common over-the-counter cold medicines that should not be taken with Doliprane 2.4%?

A: Yes, it is strictly prohibited to take this product concurrently with any other prescription or non-prescription medicine that contains Paracetamol (Acetaminophen). It is necessary to carefully check the labels of all other medicines, as concurrent use with any product containing paracetamol risks accidental overdose and severe liver damage.

Q: What are the signs of a possible allergic reaction to Doliprane 2.4%?

A: Regulatory safety information warns that serious allergic and hypersensitivity reactions, including anaphylactic shock, are rare but possible. Signs may include a rash or hives, swelling of the face, tongue, or throat, or difficulty breathing. The medicine can also, in rare cases, cause severe skin reactions like Stevens-Johnson syndrome (SJS).

Q: Can Doliprane 2.4% be taken on an empty stomach?

A: According to official administration guidelines, this medication may be taken with or without food. The official administration guidelines state the medication may be taken with or without food.

Q: Does taking Doliprane 2.4% affect the absorption of other oral medications?

A: Yes, the absorption of the active ingredient can be affected by other substances. Medicines like Metoclopramide and Domperidone can increase the rate at which Doliprane is absorbed. Conversely, Cholestyramine may slow absorption and administration should be separated by at least one hour to avoid this pharmacokinetic interaction.

Q: Is Doliprane 2.4% effective for pain caused by inflammation?

A: This medication is primarily classified as an analgesic (pain reliever) and antipyretic (fever reducer). Unlike NSAID medications such as Ibuprofen, the active ingredient, paracetamol, is generally not associated with significant anti-inflammatory action. Therefore, it treats the symptom of pain, but not the underlying inflammation.

Q: Are there any special considerations for using Doliprane 2.4% in elderly individuals?

A: Regulatory documents state that dose adjustments or frequency reductions are mandatory for patients with severe hepatic (liver) or renal (kidney) impairment. Since older adults may be more likely to have these conditions, caution is advised for those with such conditions, and usage should align with official labeling.

Q: What is the main difference between Doliprane 2.4% and regular paracetamol tablets?

A: The primary difference lies in the dosage form and target population. Doliprane 2.4% is an oral suspension (liquid) primarily intended for infants and children within specific weight parameters. Regular paracetamol tablets are a solid form, typically used by older children and adults.

Q: Why is Doliprane 2.4% available as an oral suspension (liquid)?

A: The suspension form is designed specifically for ease of administration to populations that may have difficulty swallowing solid tablets, such as infants and children. It also allows for accurate and flexible dosing based on the patient's body weight.

Q: What specific kind of pain is Doliprane 2.4% best for relieving?

A: Official product information indicates that this medication is intended for the relief of mild to moderate pain and/or fever. This includes common complaints such as headache, toothache, sore throat, and symptoms often associated with flu-like illness.

Q: Can Doliprane 2.4% cause drowsiness or affect my ability to drive?

A: The medicine is not commonly listed in regulatory documents as causing drowsiness as a regular adverse effect. However, overdose can cause drowsiness. Official labels do not typically include general warnings about driving, as the product is primarily for children.

Q: Is it normal for the suspension to have a specific taste or smell?

A: Yes, most liquid oral suspensions of paracetamol are formulated with a specific flavour or odour to make them more palatable. This is done to help make the medication easier to administer, especially to infants and children.

Q: Can Doliprane 2.4% be used to treat headaches?

A: Yes, regulatory documents clearly state that this medicine is indicated for the treatment of pain and fever, which includes pain associated with headaches.

Q: Is Doliprane 2.4% considered a non-steroidal anti-inflammatory drug (NSAID)?

A: No, Doliprane 2.4% is classified as a non-opioid analgesic (pain reliever) and antipyretic (fever reducer). It is a distinct class of medicine and is not considered an NSAID (Non-Steroidal Anti-Inflammatory Drug).

Q: What happens if I forget to take a dose of Doliprane 2.4%?

A: Regulatory documents focus on overdose prevention rather than missed doses. If a dose is missed, it remains necessary to maintain the strict minimum interval of 4 hours between administrations and to avoid exceeding the maximum total daily intake.

Q: Is it safe to take Doliprane 2.4% with prescription medications for high blood pressure?

A: The official interaction profile lists specific drug classes, but there is no general contraindication for high blood pressure medications. However, use with any concomitant prescription drug requires consultation with a healthcare professional or pharmacist to review potential interactions.

Q: Why do some people prefer the liquid suspension form over tablets or capsules?

A: Regulatory rationale for the suspension form highlights two main advantages: it is easier to administer to patients who cannot swallow solids, and it allows for flexible and accurate dosing based on the patient's specific body weight, particularly for children.

Q: How long can I continue to use Doliprane 2.4% for minor pain before needing to consult a doctor?

A: The medicine is intended for short-term relief only. Regulatory limits advise that the suspension should typically not be used for more than three days for fever or five days for pain without re-evaluation by a healthcare professional.

Q: Is there any difference in effectiveness between brand-name Doliprane 2.4% and a generic paracetamol suspension?

A: Regulatory requirements for generic medicines mandate that they must be bioequivalent to the brand-name product. This means they must deliver the same amount of active ingredient into the bloodstream at the same rate, resulting in the same therapeutic effect.

Q: What parts of the body does Doliprane 2.4% target to relieve pain?

A: The medicine works by intervening in regulatory systems within the Central Nervous System (CNS), which includes the brain and spinal cord. It modulates the activity of pain-signaling pathways, reducing the body's perception of discomfort.

Q: Is it normal to feel a mild stomach upset after taking Doliprane 2.4%?

A: Yes, while the medicine is generally well-tolerated, common side effects documented in official safety summaries can include gastrointestinal disturbances such as nausea and vomiting.

Q: Has there been much research done on the long-term effects of paracetamol in liquid form like Doliprane 2.4%?

A: Research has primarily focused on the medicine’s effectiveness over the short term. Regulatory evidence explicitly states that the long-term effects are not fully established, and current data is limited regarding its use over many months or years.

Q: Is Doliprane 2.4% commonly used for post-vaccination fever or pain?

A: Yes, paracetamol suspensions are specifically indicated in official documents for use in babies and children who may develop fever or pain following a vaccination.

Q: Why is Doliprane 2.4% sometimes recommended for toothache?

A: The medicine is indicated for the relief of mild to moderate pain, which includes pain associated with toothache. It provides symptomatic relief from the discomfort.

Q: What should I do if the liquid suspension of Doliprane 2.4% looks slightly cloudy?

A: Official guidance advises that the suspension should not be used if any change in the product's appearance is noticed, and a pharmacist or healthcare provider should be consulted.

Q: What are some very rare but serious side effects associated with paracetamol in Doliprane 2.4%?

A: The most critical safety concerns highlighted by regulatory agencies are rare but include acute liver failure (linked to high doses), severe skin reactions, and serious allergic responses like anaphylaxis.

Q: Why is this specific concentration (2.4%) used for the oral suspension?

A: The 2.4% concentration (24 mg of active ingredient per mL of liquid) is specifically chosen to facilitate accurate weight-based dosing. It ensures that the standard measuring device provided can deliver the precise milligram-per-kilogram dose required for pediatric patients in a small, easily administered volume.

Q: Does Doliprane 2.4% interact with common antacids?

A: The official interaction profile does not typically list a significant interaction with aluminum-containing antacids. Consultation with a healthcare provider or pharmacist is necessary regarding any other concomitant over-the-counter medication.

Q: Can Doliprane 2.4% cause changes in sleep patterns?

A: Some official documentation for the active ingredient lists insomnia (difficulty sleeping) as an uncommon adverse effect. If this or any other change in sleep patterns is observed, consultation with a healthcare professional is advised.

Q: How is Doliprane 2.4% different from paracetamol suspensions that are 3% or 4%?

A: The main difference is the concentration of the active ingredient (Paracetamol) in the liquid. A 2.4% suspension contains 24 mg per mL. Different concentrations are created to match specific dosing requirements and measuring devices used for various age and weight groups.

Q: Is it necessary to store Doliprane 2.4% in the refrigerator?

A: Regulatory storage requirements do not mandate refrigeration for this product. The official instruction is to not store above 25 C and to keep it in the original package, protected from light.

Q: What kind of studies have been performed to confirm the safety and efficacy of Doliprane 2.4%?

A: Regulatory evidence indicates that the medicine has been evaluated in short-term clinical trials. These studies focused on observing changes in patient-reported outcomes of pain and monitoring the evolution of body temperature (fever) in observed populations.

Q: Can Doliprane 2.4% be used for menstrual pain?

A: Yes, paracetamol is an officially indicated treatment for general aches and pains. This usage includes providing symptomatic relief from menstrual pains.

Q: Are there specific food restrictions while taking Doliprane 2.4%?

A: There are no specific food restrictions; the medicine may be taken with or without food. However, regulatory documents warn that chronic, daily ingestion of alcohol is documented to enhance the risk of liver toxicity.

Q: How long does the paracetamol from Doliprane 2.4% stay in the body's system?

A: Regulatory pharmacokinetic data suggests that the elimination half-life of paracetamol—the time required for half the dose to be removed from the body—is typically between 1 to 3 hours. The body eliminates the medicine relatively quickly through metabolism.

Advertisements

How should Doliprane 2.4% be stored and disposed of?

How to Store and Dispose of Doliprane 2.4%?

The official regulatory instructions govern the necessary environmental conditions for maintaining the stability and safety of this oral suspension. The product must be handled and disposed of according to strict guidelines to prevent environmental contamination and accidental exposure.

Official Storage Requirements

Storage Factor Regulatory Requirement
Temperature Limit Do not store above 25 C.
Protection Store in the original package, protected from light.
In-Use Stability Discard the product after the post-opening period, typically 60 days for specific formulations.
Safety Rule Always keep the medication out of the sight and reach of children.
Handling Shake the bottle for at least 10 seconds before administration.

Disposal Instructions

Unused or expired Doliprane 2.4% must not be discarded with household trash or poured into wastewater. To comply with official environmental protection rules, patients are instructed to return all unwanted medicine to a pharmacist or local collection point for appropriate disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Doliprane 2.4% found in:

A-Z Index: